Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Opiant Pharmaceuticals, Inc.

NASDAQ: OPNTHealthcare / Biotechnology / -
15.14+0.1200+0.80%Vol 17 7541Y Perf -25.62%
Jan 18th, 2019 15:59
BID8.00 ASK17.00
Open14.41 Previous Close15.02
Pre-Market- After-Trading-
 - -%  - -%
Target Price
48.00 
Analyst Rating
Strong Buy 1.00
Potencial %
217.04 
Finscreener Ranking
★★★★+     58.52
Insiders Trans % 3/6/12M
-100/-81/-22 
Value Ranking
★★★★     56.94
Insiders Value % 3/6/12M
-100/-98/-83 
Growth Ranking
★★★★     58.53
Insiders Shares Cnt. % 3/6/12M
-100/-98/-85 
Income Ranking
 —    -
Market Cap (mil)58 
Earnings Rating
Price Range Ratio 52wk %
15.40 
Earnings Date
7th Nov 2018

Today's Price Range

14.4115.20

 

52wk Range

12.0232.28

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
4.63%
3 Months
-12.03%
6 Months
3.98%
1 Year
-25.62%
3 Years
78.12%
5 Years
175.27%

Quotes

Name / TickerPriceChg.Chg.%
OPNT15.140.12000.80
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
7.80
Current Ratio
7.90
Long Term Debt to Total Capital
-
Total Debt to Equity
0.00
Interest Coverage
-2 873.20
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
39.00
EBIT Margin
12.20
EBITDA Margin
12.20
Pre-tax Profit Margin
-
Profit Margin
-22.34
ValuationValueIndustryS&P 500US Markets
PE Ratio
4.60
PB Ratio
2.18
PS Ratios
6.06
Price to Cash Flow
6.60
Price to Free Cash Flow
-179.90
Cash Flow Per Share
1.27
Price to Tangible Book
2.18
Book Value per Share
6.56
Enterprise Value (in ths.)
30 047
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
747.59
ROE last 12 Months
-69.67
Return on Assets (5Y Avg)
-11.16
ROA last 12 Months
-51.26
Return on Capital (5Y Avg)
-
ROC last 12 Months
-182.63
Return on invested Capital Q
-5.47
Return on invested Capital Y
-7.86
Assets Turnover
0.20
Receivables Turnover
0.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
9 057
Revenue per Share
2.36
Revenue Growth 3 Years
55.99
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.11-0.32-190.91
Q02 2018-1.26-0.5258.73
Q01 2018-1.19-2.77-132.77
Q04 2017-0.87-0.1780.46
Q03 2017-0.82-1.55-89.02
Q02 2017-0.854.91677.65
Q01 2017-1.14-0.3073.68
Q04 2016--0.52-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.0820.00Positive
12/2018 QR-0.1090.00Positive
12/2018 FY-4.592.34Positive
12/2019 FY2.58-34.35Negative
Next Report Date-
Estimated EPS Next Report-0.11
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume17 754
Shares Outstanding (in ths.)3 835
Trades Count62
Dollar Volume230 788
Avg. Volume24 965
Avg. Weekly Volume22 588
Avg. Monthly Volume27 832
Avg. Quarterly Volume25 060

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

43%57%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News